This post summarizes reporting and commentary from an independent medical newsletter. It is not medical advice, a treatment recommendation, or a substitute for care from a licensed clinician.

What is DMSO?

Dimethyl sulfoxide (DMSO) is a simple sulfur-containing solvent that also appears in tiny amounts in some foods and in nature. In medicine and research it has long been known for two unusual traits: it can move through skin and other membranes without destroying them, and it can carry other substances with it. Once absorbed, it spreads widely through the body and is largely cleared within days.

According to a long-form report by A Midwestern Doctor, those traits—plus antioxidant, anti-inflammatory, and cell-protective effects—make DMSO especially interesting for organs that fail quickly when blood flow stops: the brain, spinal cord, and heart.

Why strokes and spinal injuries matter

Stroke remains a leading cause of death and long-term disability. Standard clot-busting care helps some people with ischemic stroke, but only within a narrow time window, and it can be dangerous if the stroke is actually a bleed. For many traumatic brain and spinal injuries, intensive care still has limited tools to stop swelling, protect neurons, and prevent lifelong paralysis.

The article argues that DMSO, studied since the 1960s, may address several of those problems at once: reducing intracranial pressure without a classic “rebound,” improving cerebral blood flow, limiting clotting and reperfusion injury, and shielding neurons from excitotoxins, free radicals, and lack of oxygen.

What the reporting highlights

• Ischemic stroke: Animal models and a small human trial mixing DMSO with fructose diphosphate are cited as showing better neurological outcomes when treatment starts early—and sometimes even hours later.
• Hemorrhagic stroke and head trauma: Case series and ICU reports are described in which IV DMSO rapidly lowered dangerous brain pressure and, in some patients, improved responsiveness.
• Spinal and circulatory injury: The same protective pattern is linked to spinal cord trauma and conditions such as Raynaud’s, thrombophlebitis, varicose ulcers, and diabetic circulatory problems.
• Safety narrative: The author emphasizes a long record of use with mostly mild side effects (skin irritation, garlic-like odor) and rare allergy, while arguing that FDA restrictions decades ago blocked broader clinical adoption.

Circulation, “blood sludging,” and nerves

A major theme of the piece is microcirculation. Drawing on older work on blood cell clumping and related ideas about fluid dynamics in the body, the author suggests many neurological problems worsen when tiny vessels clog or slow. DMSO, in this view, does not simply raise electrical repulsion between cells; instead it may reduce aggregation, thin pathological gels, support lymphatic flow, and keep white cells from sticking to inflamed vessel walls—effects that could matter in stroke, heat injury, and chronic neurologic decline.

How to read this carefully

Much of the cited literature is older, veterinary, overseas, or small-scale. Dramatic anecdotes (home treatment of suspected stroke, recovery after coma) appear alongside formal studies. That mix is useful for curiosity and historical context, but it is not the same as large modern randomized trials that define standard of care.

If you are interested in DMSO for any neurologic or circulatory condition, discuss evidence, purity, dosing, drug interactions, and legal status with a qualified healthcare professional. Do not delay emergency care for stroke or spinal injury.

Source

Original article: DMSO Could Save Millions From Brain and Spinal Injury — A Midwestern Doctor, The Forgotten Side of Medicine (Sept. 15, 2024).